fool.com · 3 jul

Where Will TransMedics Group Stock Be in 10 Years?

TransMedics is building more than a medical device business. Its Organ Care System and nationwide transplant logistics network create a difficult-to-replicate competitive advantage.

fool.com · 2 jul

3 Growth Stocks to Buy on the Dip

Investing in attractive stocks on the dip is a great way to earn above-average returns over the long run. The three stocks below have faced some challenges, but their prospects look fairly strong.

zacks.com · 30 jun

Reasons to Retain TransMedics Stock in Your Portfolio for Now

TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.

fool.com · 24 jun

What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop

Specializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.

globenewswire.com · 12 jun

Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP Investments

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating TransMedics Group, Inc. (NASDAQ: TMDX) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.

seekingalpha.com · 9 jun

TransMedics: Why I'm Still Bullish After The Collapse

TransMedics (TMDX) faces decelerating revenue growth, margin pressure, and increased investment, yet maintains strong market share gains and competitive positioning. TMDX's logistics and clinical services now comprise nearly 40% of revenue, enhancing competitive advantages and supporting long-term margin strength. Despite growth normalizing to 20-25% and compressed margins, I see current valuation at 4x EV/Sales as attractive, supporting a Buy rating.

fool.com · 5 jun

3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market

Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.

zacks.com · 4 jun

TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?

TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?